News
Consumers are more interested in buying a product they hear great things about. But there’s a hidden downside to all the good vibes.
Bitcoin ( BTC-USD) is expected to rise marginally, 1.1% on a weekly basis, as market sentiments seem to improve on the back ...
CLEVELAND, May 15, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today reported financial results and business highlights for the first quarter of 2025 and shared recent operational ...
About PYRUKYND® (mitapivat) U.S. INDICATION PYRUKYND is a pyruvate kinase activator indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results